Challenges on management of heart failure in Indonesia: a general practitioner’s perspective
Abstract
Heart failure has become a public health problem with increasing incidence and prevalence. Many patients first came to the primary care and managed by general practitioner. Accurate diagnosis is essential to provide good management of heart failure. However, symptoms and signs alone are often neither sufficient nor specific to confirm the diagnosis. Some studies show that heart failure patients are still incorrectly diagnosed and inadequately treated, despite the availability of current guidelines. Inadequacy of facilities is the main obstacle in diagnosing and managing heart failure, especially in developing countries like Indonesia. The medications recommended for treating heart failure are still under-prescribed. This review discuss about the challenges of diagnosis and management of heart failure in primary care.
Keywords: heart failure, general practice, primary care
References
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012;33(14):1787-847. http://dx.doi.org/10.1093/eurheartj/ehs104
Khunti K, Hearnshaw H, Baker R, Grimshaw G. Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail. 2002;4(6):771-7. http://dx.doi.org/10.1016/S1388-9842(02)00119-8
Hobbs FDR, Korewicki J, Cleland JGF, Eastaugh J, Freemantle N, and on behalf of the IMPROVEMENT investigators. The diagnosis of heart failure in European primary care: The IMPROVEMENT programme survey of perception and practice. Eur J Heart Fail. 2005;7(5):768-79. http://dx.doi.org/10.1016/j.ejheart.2005.01.018
Fox KF, Cowie MR, Wood DA, Coats AJ, Poole-Wilson PA, Sutton GC. A rapid access heart failure clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community. Eur J Heart Fail. 2000;2(4):423-9. http://dx.doi.org/10.1016/S1388-9842(00)00108-2
de Giuli F, Khaw KT, Cowie MR, Sutton GC, Ferrari R, Poole-Wilson PA. Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom. Eur J Heart Fail. 2005;7(3):295-302. http://dx.doi.org/10.1016/j.ejheart.2004.10.017
McDonald K. Current guidelines in the management of chronic heart failure: Practical issues in their application to the community population. Eur J Heart Fail. 2005;7(3): 317-21. http://dx.doi.org/10.1016/j.ejheart.2005.01.013
McGeoch G, Lainchbury J, Town GI, Toop L, Espiner E, Richards AM. Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Fail. 2002;4(4):479-83. http://dx.doi.org/10.1016/S1388-9842(02)00027-2
Sparrow N, Adlam D, Cowley A, Hampton JR. The diagnosis of heart failure in general practice: implications for the UK National Service Framework. Eur J Heart Fail. 2003;5(3):349-54. http://dx.doi.org/10.1016/S1388-9842(03)00047-3
Kelder JC, Cramer MJ, Rutten FH, Plokker HW, Grobbee DE, Hoes AW. The furosemide diagnostic test in suspected slow-onset heart failure: popular but not useful. Eur J Heart Fail. 2011;13(5):513-7. http://dx.doi.org/10.1093/eurjhf/hfr010
Rutten FH, Grobbee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail. 2003;5(3):337-44. http://dx.doi.org/10.1016/S1388-9842(03)00050-3
Pont LG, van Gilst WH, Lok DJ, Kragten HJ, Haaijer-Ruskamp FM; Dutch Working Group on Heart Failure. The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice. Eur J Heart Fail. 2003;5(2):187-93. http://dx.doi.org/10.1016/S1388-9842(02)00202-7
McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs FD, et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers ¨in heart failure: Putting guidelines into practice. Eur J Heart Fail. 2005;7(5):710-21. http://dx.doi.org/10.1016/j.ejheart.2005.07.002
Sparrow N, Adlam D, Cowley A, Hampton JR. Difficulties of introducing the National Service Framework for heart failure into general practice in the UK. Eur J Heart Fail. 2003;5(3):355-61. http://dx.doi.org/10.1016/S1388-9842(03)00047-3
de Groote P, Isnard R, Assyag P, Clerson P, Ducardonnet A, Galinier M, et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail. 2007;9(12):1205-11. http://dx.doi.org/10.1016/j.ejheart.2007.09.008
Siswanto BB, Radi B, Kalim H, Santoso A, Suryawan R, Erwinanto, et al. Heart Failure in NCVC Jakarta and 5 hospitals in Indonesia. CVD Prevention and Control. 2010;5(1): 35-8. http://dx.doi.org/10.1016/j.cvdpc.2010.03.005
Rukmini, Rosihermiatie B, Nantabah Z. Availability and eligibility of primary health center room for services based on topography demography and geography in Indonesia. Bulletin on Health System Research. 2012;15(4):408-17.
Copyright (c) 2014 Rizki Rizki, Bambang B. Siswanto
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.
